Delivery Order HHSO100201200014I-HHSO10033008T

Award Date 5/30/13
Potential Completion Date 8/31/15
Potential Value $10M
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Oakland, CA 94608, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for ASPR-13-06002 -- FUNDING FOR CSL CLIN 0001 CGMP INFLUENZA VACCINE OPTIMIZED MASTER AND WORKING SEED LOT HHSO100201200011I, with a ceiling value of $150,000.00. The contract was awarded to Seqirus USA Inc., through its Seqirus Usa, Inc. Division, a global biotechnology company specializing in influenza vaccine development and delivery. The contract is a Delivery Order under the Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract...
This is a delivery order award to Glaxosmithkline, LLC under the Pandemic Influenza Preparedness and Response 2012-2016 indefinite delivery/indefinite quantity (IDIQ) contract with the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR). The $2,812,228.00 fixed-price order is for the production of clinical lots of a CGMP (current good manufacturing practice) influenza vaccine. This supports the Acquisition of Medical...
This is a $2,500,000.00 firm fixed price delivery order contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to MedImmune LLC. The contract is for the production of a Coronavirus Genomics Manufacturing and Production (CGMP) influenza vaccine clinical lot under the Pandemic Influenza Preparedness and Response 2012-2016 contract vehicle. There is no set-aside designation for this award. The ultimate...
This is a delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) to GlaxoSmithKline, LLC, a pharmaceutical company, under the Pandemic Influenza Preparedness and Response 2012-2016 contract. The contract is for the production of non-GMP influenza vaccine plots at a firm fixed price of $149,412.00. The award supports ASPR's broader efforts for pandemic influenza preparedness and response, including disease...
This federal contract award was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The purpose of this Firm Fixed Price Delivery Order is to procure an Influenza A(H2Nx) virus vaccine candidate(s) and conduct the associated clinical trial. The total ceiling value of this contract is $21,404,609.80, with a completion date of January 31, 2027. The prime contractor is Seqirus Inc.,...
This is a firm fixed price delivery order awarded to Sanofi Pasteur Inc. by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The contract supports the Acquisition of Medical Countermeasures for Pandemic Influenza Preparedness and Response program, with a ceiling value of $772,708.47. Sanofi Pasteur Inc., as the prime contractor, will provide formulation and fill services for H7N9 influenza vaccine clinical...
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $680,955.00 firm fixed price delivery order contract to Sanofi Pasteur Inc. for the acquisition of egg-based influenza master and working seed lots derived from a specific A/American Wigeon/South Carolina/22-000345-001/2021 (H5N1) candidate vaccine virus, as well as the fill-finish of any existing egg-based A/American Wigeon/South Carolina/22-000345/2021...
This is a firm fixed price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Glaxosmithkline, LLC to provide the acquisition of egg-based influenza master and working seed lots derived from a specific candidate vaccine virus, as well as fill-finish of any existing egg-based influenza vaccines. The order has a ceiling value of $1,650,050.61 and a completion date of February 21, 2026. No set-aside designation was used....
This federal contract award, identified as HHSO100201200011I|HHSO10033008T, is a delivery order for RTOR 2015-002 issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency. The contract has a ceiling value of $8,420,100.00 and was awarded to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development, manufacturing, and delivery. The contract does not have a set-aside designation. Seqirus USA Inc., through its...
This federal contract award, identified as 75A50118P00012, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The $42,247 firm fixed-price purchase order was awarded to Seqirus Inc., a foreign-owned, for-profit manufacturer of medical countermeasures, vaccines, and related products. The contract has no set-aside designation and was issued under Seqirus' $13.4 billion Indefinite...

ASPR-13-06568 -- NVD-CLIN 0003 CGMP INFLUENZA VACCINE CLINICAL LOT UNDER CONTRACT HHSO100201200014I

Posted 5/30/13